Isotechnika Pharma Inc IPHAF

RE: Jump at close

[BornReady1970]

There was no jump. the 40k was sold at 22.5 cents. It just happens that the bid-ask spread widend.

I have two questions/comments for the ISA investor:

1) Just out of interest... for recent buyers what price do you think the share price will move to if Aug 3rd turns out to be a minor 3 month delay? I find it highly improbable that the price would shoot up over
.40 since it ranged between
.25 and
.40 for the three months before the last potential approval date. So what are inventors really looking at?

A highly risky return in the range of 10% to 50% or a total wipe out if the news is against them. Why not just buy an in the money leap option on a blue chip instead? Same reward with less risk. If the news is moderately good it is easy enough to jump on and ride the wave after the news release.

2) From the news release...

"At this time, the FDA has not communicated all the outstanding issues to Lux for the uveitis application," stated Dr. Robert Foster, President and CEO of Isotechnika Pharma. "They await the action letter from the FDA which is expected on or near the PDUFA date of August 3, 2010 for further clarification."

and from the FDA website...

"Once a drug receives Fast Track designation, ealy and frequent communication between the FDA and a drug company is encouraged throughout the entire drug development and review process. the frequency of communication assures that questions and issues are resolved quickly, often leading to earlier drug approval and access by patients."

Foster's claim that the FDA hasn't communicated is totally inconsistent with a drug that has Fast Track status.